secwatch.observer — SEC 8-K summary
======================================

Issuer:     VitaNova Life Sciences Corp (VNOV)
CIK:        0001699709
Form:       8-K
Filed at:   2023-06-15T23:59:59+00:00
Accession:  0001683168-23-004181
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xianchang Ma acquires 86.3% of Yijia Group; appointed CEO, President, CFO and Director
--------------------------------------------------------------------------------

- Barry Sytner sold 5,066,250 shares (86.3% of outstanding) to Xianchang Ma for $470,562 on June 14, 2023.
- Sytner resigned as CEO, President, CFO, and Director; Ma appointed to all those roles effective June 14, 2023.
- Xianchang Ma, age 48, is CEO and director of Tengjun Biotechnology Corp; founded Jinan Tengiun Biological Technology in 2014.
- Purchase price paid from Ma's personal funds; agreement included escrow and conditions such as filing of Form 10-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699709/000168316823004181/0001683168-23-004181-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699709/000168316823004181/yijia_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-004181

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer